The Women's - The Royal Women's Hospital Victoria
homeour serviceshealth informationhealth professionalsour researchabout ussupport the women's
The Women's Home
Search The Womens' Website 

latex allergy management


Latex Allergy Management

Purpose


This clinical practice guideline relates to the management of patients with known latex allergy (Type 1 hypersensitivity) and patients who are at high risk of developing latex allergy at the Royal Women's Hospital (the Women's).

Types of latex allergy


There are three types of latex allergy reactions:

1. Irritant Dermatitis: a dermatitis caused by chemical irritation that does not involve the immune system.

2. Allergic Contact Dermatitis: (Type IV hypersensitivity, Cell mediated or delayed type hypersensitivity). This is a type of allergic contact dermatitis that may be caused by the chemicals used in latex production and involves the immune system.
Type IV reactions are limited to areas of contact. They occur several hours after exposure and are not usually life threatening.


3. Type I hypersenstivity: (Immediate, IgE mediated hypersensitivity).
These are true allergic reactions to proteins in the latex.
Reactions may include a local wheal and flare response, urticaria, generalised swelling and wheezing progressing up to a full blown anaphylactic reaction.


High risk groups


The following categories may help identify persons who are at risk of having or developing latex sensitivity. Incidence may be greater than 60%.

  • Patients who have undergone repeated bladder catheterisation. This most commonly occurs in patients with spina bifida or neural tube defects.
  • Healthcare workers.
  • Patients with an occupational exposure to latex.
  • Patients who have undergone multiple surgical procedures.
  • Patients with a history of atopy or food allergy particularly to fruits such as avocados, bananas and kiwi fruit.

History


  • People who have experienced swelling, itching or other symptoms following contact with rubber products e.g. dental, rectal or pelvic exam.
  • Swelling of lips or tongue after blowing up a balloon
  • After using a diaphragm or condom
  • Whilst wearing stretchy or spandex underclothing

Assessment / Investigations


  • Question for latex allergy in all high risk groups.
  • If possible refer patients at high risk for preoperative testing.
  • Patients with known or suspected history of anaphylaxis to latex should be treated as having a latex allergy.
  • All patients with known or suspected latex allergy should be referred to the anaesthetic department preoperatively or on admission to the hospital or birthing suites.
  • A therapeutic plan should be developed for each latex allergy patient to prevent their exposure to latex during their hospital stay.


Management


Each hospital clinical area needs to formulate its own procedures for preventing latex exposure for at risk patients. Key principles are:

Identification


  • Patients with known or suspected latex allergy (type 1 hypersensitivity) should wear an appropriate allergy alert bracelet and an allergy alert should be entered in their history.

Avoidance of latex exposure:


  • NO powdered latex gloves should be used in any part of the hospital.
  • Latex free gloves should be available in all clinical areas of the hospital and used for ALL latex sensitive patients.

Additional precautions for patients with type 1 hypersensitivity:


  • Patients’s room, birth suite, operating theatre, ED cubicle should have latex products removed from it and substituted with latex free alternatives.

  • The latex status of products on imprest at the Women's can be obtained from the Royal Children's Hospital Material Resources website (shared site). Refer to: Stock Catalogue RWH & RMH (Excel). Many products used at the Women's e.g. syringes, IV lines are now latex free.

  • A latex officer should be nominated by each department to prepare a list of essential equipment that is safe to be used for latex sensitive patients. This could be kept as a list or latex free box.

In addition to above consider the following procedures for individual clinical areas:

Surgery
  • Operating Suite and or booking office should be notified of any patients with latex allergy admitted for surgery or to Birthing suites. At the Women's latex allergy should be noted in the ORMIS information system.
  • Where possible Latex allergy patients undergoing elective procedures in the operating room should be booked as the first case on the list. This will allow adequate time to prepare the OR.
  • The operating theatre must have signs attached to all entrances to ensure latex safe area.
  • Operating theatre table mattress and arm boards must be completely covered with linen.
  • Only when the operating room is prepared is the patient to be sent for.
  • Patients should wear balaclavas with ties not elastic hats or other elastic containing disposable clothing.
  • Latex free product list must be consulted to ensure all equipment used for surgery and anaesthesia is latex free.
  • Patient should either be recovered in theatre or an area of PACU that can be prepared as a latex free area.
  • On return to the ward the PACU nurse must ensure that ward staff are aware of the patient’s latex allergy and that they are returning to an appropriate latex free environment.

Birth Suites, ED, Wards
Patient should be managed in a single room where possible. This room should have signs attached to all entrances to ensure a latex safe area.
Ensure equipment used for procedures/monitoring is latex free by consulting latex free list.
Ensure other departments are aware of the patient’s latex allergy if the patient has to go to another area during their hospital admission.



Prophylaxis


Routine pre-operative steroid and antihistamine prophylaxis is not currently recommended for either true allergy patients or those at high risk.

Treatment


Staff should be vigilant for the possibility of anaphylaxis in all patients with known or suspected latex allergy.

When anaphylaxis is suspected an adult code blue should be called and treatment should follow established guidelines for treating anaphylaxis. Refer to:
American Heart Association reference below.

References



Evidence table
Latex allergy: management evidence table
(pdf 26kb)

2 August 2007


Royal Women's Hospital Clinical Practice Guidelines (CPGs) are intended to provide guidance to health care professionals, based on a thorough evaluation of research evidence, on the practical assessment and management of specific clinical issues or situations. The guidelines allow some flexibility on the part of the health care professional based on the needs of the specific patient for whom they are caring.

Please remember to read our disclaimer.

Powered by Komodo CMS